Sacha T. Deep molecular response (MR4.5) as a target of therapy with tyrosine kinase inhibitors. MR4.5 – goal of CML treatment. OncoReview [Internet]. 2014Mar.31 [cited 2024Jul.3];4(1(13):26-2. Available from: https://journalsmededu.pl/index.php/OncoReview/article/view/356